What is the product intended to do?
Trust begins with a defined use, user, population, setting, and product version.
Independent evaluation for medical AI
Artificial intelligence is changing medicine.Evidence should decide what earns trust.
Real Intelligence Review makes AI-enabled health products easier to examine. The Atlas organizes products and public evidence. The Standard explains how claims should be assessed for a defined clinical use.
The question of trust
Confidence should be proportional to clinical consequence.
Medical AI can influence what people understand, what clinicians notice, and which actions are considered. Clear evidence, scope, and limitations make those products easier to judge responsibly.
What does the evidence support?
Claims, studies, regulatory information, and important limitations should be examined together.
What remains uncertain?
Unknowns and contradictory evidence should remain visible rather than becoming false certainty.
Two connected resources
See the market clearly. Understand how evidence is judged.
Real Intelligence Atlas
Clinical AI, mapped.
Search structured product profiles, review the public evidence identified for each product, and see what remains uncertain. Recent evidence and regulatory updates now live alongside the directory.
Explore 1,859 recordsReal Intelligence Standard
A defined standard for a defined use.
The Standard brings principles, evidence requirements, evaluation methods, and publication rules into one risk-sensitive framework.
Read the frameworkIndependent assessment
Findings should show their evidence, scope, and uncertainty.
Every conclusion is limited to a defined product version and clinical use.
Evidence requirements rise with the foreseeable consequence of error.
Applicant funding does not guarantee a favorable finding or publication.